0 XP   0   0   0

BIOCON LTD.
Buy, Hold or Sell?

Should you buy, hold or sell Biocon?

I guess you are interested in BIOCON LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Biocon

Let's start. I'm going to help you getting a better view of BIOCON LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is BIOCON LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how BIOCON LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value BIOCON LTD.. The closing price on 2023-01-27 was INR235.50 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
BIOCON LTD. Daily Candlestick Chart
BIOCON LTD. Daily Candlestick Chart
Summary









1. Valuation of Biocon




Current price per share

INR235.50

2. Growth of Biocon




Is Biocon growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$938.1m$99m9.6%

How much money is Biocon making?

Current yearPrevious yearGrowGrow %
Making money$79.7m$91m-$11.3m-14.2%
Net Profit Margin7.9%10.4%--

How much money comes from the company's main activities?

3. Financial Health of Biocon




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  


Richest
#8 / 1232

Most Revenue
#6 / 1232

Most Profit
#9 / 1232

Most Efficient
#162 / 1232


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of BIOCON LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biocon earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Biocon to the Biotechnology industry mean.
  • A Net Profit Margin of 7.9% means that ₹0.08 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BIOCON LTD.:

  • The MRQ is 7.9%. The company is making a profit. +1
  • The TTM is 7.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.9%TTM7.9%0.0%
TTM7.9%YOY10.4%-2.4%
TTM7.9%5Y11.1%-3.2%
5Y11.1%10Y13.1%-2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9%-223.6%+231.5%
TTM7.9%-281.7%+289.6%
YOY10.4%-344.8%+355.2%
5Y11.1%-450.1%+461.2%
10Y13.1%-541.0%+554.1%
1.1.2. Return on Assets

Shows how efficient Biocon is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biocon to the Biotechnology industry mean.
  • 3.2% Return on Assets means that Biocon generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BIOCON LTD.:

  • The MRQ is 3.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.2%TTM3.2%0.0%
TTM3.2%YOY4.0%-0.8%
TTM3.2%5Y4.7%-1.5%
5Y4.7%10Y5.7%-1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2%-9.9%+13.1%
TTM3.2%-8.9%+12.1%
YOY4.0%-9.3%+13.3%
5Y4.7%-11.7%+16.4%
10Y5.7%-12.7%+18.4%
1.1.3. Return on Equity

Shows how efficient Biocon is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biocon to the Biotechnology industry mean.
  • 7.7% Return on Equity means Biocon generated ₹0.08 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BIOCON LTD.:

  • The MRQ is 7.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.7%TTM7.7%0.0%
TTM7.7%YOY9.7%-2.0%
TTM7.7%5Y10.1%-2.4%
5Y10.1%10Y11.8%-1.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7%-12.0%+19.7%
TTM7.7%-11.5%+19.2%
YOY9.7%-10.8%+20.5%
5Y10.1%-14.2%+24.3%
10Y11.8%-15.2%+27.0%

1.2. Operating Efficiency of BIOCON LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biocon is operating .

  • Measures how much profit Biocon makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biocon to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BIOCON LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.9%-8.9%
5Y8.9%10Y12.3%-3.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y8.9%-454.0%+462.9%
10Y12.3%-537.1%+549.4%
1.2.2. Operating Ratio

Measures how efficient Biocon is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.29 means that the operating costs are ₹1.29 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of BIOCON LTD.:

  • The MRQ is 1.285. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.285. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.285TTM1.2850.000
TTM1.285YOY1.284+0.002
TTM1.2855Y1.276+0.010
5Y1.27610Y1.282-0.006
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2852.871-1.586
TTM1.2853.504-2.219
YOY1.2843.604-2.320
5Y1.2765.132-3.856
10Y1.2826.371-5.089

1.3. Liquidity of BIOCON LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biocon is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.19 means the company has ₹2.19 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of BIOCON LTD.:

  • The MRQ is 2.190. The company is able to pay all its short-term debts. +1
  • The TTM is 2.190. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.190TTM2.1900.000
TTM2.190YOY1.805+0.384
TTM2.1905Y1.774+0.416
5Y1.77410Y1.914-0.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1905.117-2.927
TTM2.1905.755-3.565
YOY1.8055.854-4.049
5Y1.7746.511-4.737
10Y1.9146.222-4.308
1.3.2. Quick Ratio

Measures if Biocon is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biocon to the Biotechnology industry mean.
  • A Quick Ratio of 1.93 means the company can pay off ₹1.93 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BIOCON LTD.:

  • The MRQ is 1.930. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.930. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.930TTM1.9300.000
TTM1.930YOY1.670+0.260
TTM1.9305Y1.686+0.244
5Y1.68610Y1.753-0.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9304.284-2.354
TTM1.9304.664-2.734
YOY1.6704.787-3.117
5Y1.6865.218-3.532
10Y1.7535.182-3.429

1.4. Solvency of BIOCON LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biocon assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biocon to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.59 means that Biocon assets are financed with 58.7% credit (debt) and the remaining percentage (100% - 58.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BIOCON LTD.:

  • The MRQ is 0.587. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.587. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.587TTM0.5870.000
TTM0.587YOY0.588-0.002
TTM0.5875Y0.538+0.048
5Y0.53810Y0.513+0.025
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5870.278+0.309
TTM0.5870.277+0.310
YOY0.5880.306+0.282
5Y0.5380.367+0.171
10Y0.5130.403+0.110
1.4.2. Debt to Equity Ratio

Measures if Biocon is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biocon to the Biotechnology industry mean.
  • A Debt to Equity ratio of 141.8% means that company has ₹1.42 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BIOCON LTD.:

  • The MRQ is 1.418. The company is able to pay all its debts with equity. +1
  • The TTM is 1.418. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.418TTM1.4180.000
TTM1.418YOY1.429-0.010
TTM1.4185Y1.186+0.233
5Y1.18610Y1.082+0.104
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4180.315+1.103
TTM1.4180.317+1.101
YOY1.4290.319+1.110
5Y1.1860.403+0.783
10Y1.0820.462+0.620

2. Market Valuation of BIOCON LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Biocon generates.

  • Above 15 is considered overpriced but always compare Biocon to the Biotechnology industry mean.
  • A PE ratio of 61.95 means the investor is paying ₹61.95 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BIOCON LTD.:

  • The EOD is 43.606. Good. +1
  • The MRQ is 61.946. Neutral. Compare to industry.
  • The TTM is 61.946. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD43.606MRQ61.946-18.340
MRQ61.946TTM61.9460.000
TTM61.946YOY66.247-4.301
TTM61.9465Y88.811-26.865
5Y88.81110Y111.958-23.147
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD43.606-8.986+52.592
MRQ61.946-9.792+71.738
TTM61.946-16.243+78.189
YOY66.247-20.876+87.123
5Y88.811-16.665+105.476
10Y111.958-14.732+126.690
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Biocon.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of BIOCON LTD.:

  • The MRQ is 70.781. Seems overpriced? -1
  • The TTM is 70.781. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ70.781TTM70.7810.000
TTM70.781YOY66.936+3.845
TTM70.7815Y107.652-36.871
5Y107.65210Y115.912-8.260
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ70.781-0.032+70.813
TTM70.7810.004+70.777
YOY66.9360.016+66.920
5Y107.6520.006+107.646
10Y115.9120.003+115.909

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biocon is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.76 means the investor is paying ₹4.76 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of BIOCON LTD.:

  • The EOD is 3.353. Neutral. Compare to industry.
  • The MRQ is 4.763. Neutral. Compare to industry.
  • The TTM is 4.763. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.353MRQ4.763-1.410
MRQ4.763TTM4.7630.000
TTM4.763YOY6.432-1.669
TTM4.7635Y8.365-3.602
5Y8.36510Y13.002-4.637
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.3531.835+1.518
MRQ4.7632.006+2.757
TTM4.7632.774+1.989
YOY6.4323.453+2.979
5Y8.3652.713+5.652
10Y13.0022.402+10.600
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BIOCON LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.6786.6780%7.676-13%5.984+12%7.804-14%
Book Value Growth--1.1061.1060%1.137-3%1.118-1%1.134-2%
Book Value Per Share--70.23670.2360%63.558+11%56.733+24%45.799+53%
Book Value Per Share Growth--1.1051.1050%1.137-3%1.118-1%1.134-3%
Current Ratio--2.1902.1900%1.805+21%1.774+23%1.914+14%
Debt To Asset Ratio--0.5870.5870%0.5880%0.538+9%0.513+14%
Debt To Equity Ratio--1.4181.4180%1.429-1%1.186+20%1.082+31%
Dividend Per Share----0%-0%0.346-100%0.695-100%
Eps--5.4015.4010%6.171-12%5.691-5%5.082+6%
Eps Growth--0.8750.8750%0.990-12%1.146-24%1.144-23%
Free Cash Flow Per Share---6.232-6.2320%-4.888-22%-4.133-34%-3.460-44%
Free Cash Flow Per Share Growth--0.7250.7250%0.940-23%-1.070+248%-0.340+147%
Free Cash Flow To Equity Per Share---4.215-4.2150%16.478-126%0.388-1188%0.443-1052%
Free Cash Flow To Equity Per Share Growth---0.256-0.2560%13.926-102%2.965-109%1.976-113%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--58.179--------
Intrinsic Value_10Y_min--45.913--------
Intrinsic Value_1Y_max---3.640--------
Intrinsic Value_1Y_min---3.537--------
Intrinsic Value_3Y_max---3.719--------
Intrinsic Value_3Y_min---3.641--------
Intrinsic Value_5Y_max--4.903--------
Intrinsic Value_5Y_min--3.911--------
Net Profit Margin--0.0790.0790%0.104-24%0.111-29%0.131-40%
Operating Margin----0%-0%0.089-100%0.123-100%
Operating Ratio--1.2851.2850%1.284+0%1.276+1%1.282+0%
Pb Ratio3.353-42%4.7634.7630%6.432-26%8.365-43%13.002-63%
Pe Ratio43.606-42%61.94661.9460%66.247-6%88.811-30%111.958-45%
Peg Ratio--70.78170.7810%66.936+6%107.652-34%115.912-39%
Price Per Share235.500-42%334.550334.5500%408.800-18%443.830-25%525.366-36%
Price To Total Gains Ratio35.264-42%50.09650.0960%53.258-6%79.487-37%85.495-41%
Profit Growth--0.8760.8760%0.990-12%1.146-24%1.144-23%
Quick Ratio--1.9301.9300%1.670+16%1.686+14%1.753+10%
Return On Assets--0.0320.0320%0.040-20%0.047-32%0.057-44%
Return On Equity--0.0770.0770%0.097-21%0.101-24%0.118-35%
Revenue Growth--1.1461.1460%1.134+1%1.162-1%1.142+0%
Total Gains Per Share--6.6786.6780%7.676-13%6.330+5%8.499-21%
Total Gains Per Share Growth--0.8700.8700%1.373-37%1.155-25%1.107-21%
Usd Book Value--1037197500.0001037197500.0000%938108700.000+11%837482400.000+24%676053100.000+53%
Usd Book Value Change Per Share--0.0820.0820%0.094-13%0.074+12%0.096-14%
Usd Book Value Per Share--0.8640.8640%0.782+11%0.698+24%0.563+53%
Usd Dividend Per Share----0%-0%0.004-100%0.009-100%
Usd Eps--0.0660.0660%0.076-12%0.070-5%0.063+6%
Usd Free Cash Flow---92028600.000-92028600.0000%-72151800.000-22%-61008000.000-34%-33893333.333-63%
Usd Free Cash Flow Per Share---0.077-0.0770%-0.060-22%-0.051-34%-0.043-44%
Usd Free Cash Flow To Equity Per Share---0.052-0.0520%0.203-126%0.005-1188%0.005-1052%
Usd Price Per Share2.897-42%4.1154.1150%5.028-18%5.459-25%6.462-36%
Usd Profit--79753200.00079753200.0000%91081500.000-12%84004080.000-5%75009500.000+6%
Usd Revenue--1006632000.0001006632000.0000%878601300.000+15%769283820.000+31%608732466.667+65%
Usd Total Gains Per Share--0.0820.0820%0.094-13%0.078+5%0.105-21%
 EOD+3 -2MRQTTM+0 -0YOY+12 -265Y+15 -2610Y+15 -26

3.2. Fundamental Score

Let's check the fundamental score of BIOCON LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1543.606
Price to Book Ratio (EOD)Between0-13.353
Net Profit Margin (MRQ)Greater than00.079
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.930
Current Ratio (MRQ)Greater than12.190
Debt to Asset Ratio (MRQ)Less than10.587
Debt to Equity Ratio (MRQ)Less than11.418
Return on Equity (MRQ)Greater than0.150.077
Return on Assets (MRQ)Greater than0.050.032
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of BIOCON LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose236.050
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets203,940,000
Total Liabilities119,615,000
Total Stockholder Equity84,325,000
 As reported
Total Liabilities 119,615,000
Total Stockholder Equity+ 84,325,000
Total Assets = 203,940,000

Assets

Total Assets203,940,000
Total Current Assets83,823,000
Long-term Assets83,823,000
Total Current Assets
Cash And Cash Equivalents 6,326,000
Short-term Investments 23,019,000
Net Receivables 21,201,000
Inventory 24,270,000
Other Current Assets 1,230,000
Total Current Assets  (as reported)83,823,000
Total Current Assets  (calculated)76,046,000
+/- 7,777,000
Long-term Assets
Property Plant Equipment 93,643,000
Goodwill 264,000
Intangible Assets 12,887,000
Other Assets 5,209,000
Long-term Assets  (as reported)120,117,000
Long-term Assets  (calculated)112,003,000
+/- 8,114,000

Liabilities & Shareholders' Equity

Total Current Liabilities38,280,000
Long-term Liabilities70,960,000
Total Stockholder Equity84,325,000
Total Current Liabilities
Short-term Debt 8,960,000
Short Long Term Debt 9,055,000
Accounts payable 16,085,000
Other Current Liabilities 320,000
Total Current Liabilities  (as reported)38,280,000
Total Current Liabilities  (calculated)34,420,000
+/- 3,860,000
Long-term Liabilities
Long term Debt Total 42,200,000
Capital Lease Obligations 2,426,000
Long-term Liabilities Other 12,151,000
Long-term Liabilities  (as reported)70,960,000
Long-term Liabilities  (calculated)56,777,000
+/- 14,183,000
Total Stockholder Equity
Common Stock6,003,000
Retained Earnings 73,919,000
Capital Surplus 619,000
Other Stockholders Equity 2,058,000
Total Stockholder Equity (as reported)84,325,000
Total Stockholder Equity (calculated)82,599,000
+/- 1,726,000
Other
Capital Stock6,003,000
Cash And Equivalents300,000
Cash and Short Term Investments 29,645,000
Common Stock Shares Outstanding 1,200,600
Liabilities and Stockholders Equity 203,940,000
Net Debt 42,414,000
Net Invested Capital 133,365,000
Net Working Capital 45,543,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
57,506,000
63,754,000
84,581,000
93,942,000
99,897,000
121,924,000
144,438,000
185,223,000
203,940,000
203,940,000185,223,000144,438,000121,924,00099,897,00093,942,00084,581,00063,754,00057,506,000
   > Total Current Assets 
26,388,000
25,626,000
39,709,000
40,477,000
41,486,000
48,885,000
53,250,000
76,004,000
83,823,000
83,823,00076,004,00053,250,00048,885,00041,486,00040,477,00039,709,00025,626,00026,388,000
       Cash And Cash Equivalents 
8,044,000
9,375,000
550,000
6,000
1,050,000
7,289,000
653,000
9,372,000
6,326,000
6,326,0009,372,000653,0007,289,0001,050,0006,000550,0009,375,0008,044,000
       Short-term Investments 
7,005,000
2,305,000
16,517,000
13,988,000
14,327,000
11,564,000
9,458,000
22,707,000
23,019,000
23,019,00022,707,0009,458,00011,564,00014,327,00013,988,00016,517,0002,305,0007,005,000
       Net Receivables 
6,839,000
8,235,000
8,065,000
10,975,000
12,554,000
16,784,000
16,790,000
15,367,000
21,201,000
21,201,00015,367,00016,790,00016,784,00012,554,00010,975,0008,065,0008,235,0006,839,000
       Inventory 
3,766,000
4,527,000
5,424,000
6,353,000
7,225,000
10,316,000
14,359,000
19,333,000
24,270,000
24,270,00019,333,00014,359,00010,316,0007,225,0006,353,0005,424,0004,527,0003,766,000
       Other Current Assets 
734,000
1,184,000
671,000
1,303,000
1,545,000
2,309,000
2,853,000
1,363,000
1,230,000
1,230,0001,363,0002,853,0002,309,0001,545,0001,303,000671,0001,184,000734,000
   > Long-term Assets 
0
0
0
53,465,000
58,411,000
73,696,000
91,188,000
109,219,000
120,117,000
120,117,000109,219,00091,188,00073,696,00058,411,00053,465,000000
       Property Plant Equipment 
25,866,000
30,745,000
37,408,000
40,856,000
44,086,000
55,396,000
70,980,000
79,641,000
93,643,000
93,643,00079,641,00070,980,00055,396,00044,086,00040,856,00037,408,00030,745,00025,866,000
       Goodwill 
122,000
264,000
264,000
264,000
264,000
264,000
264,000
264,000
264,000
264,000264,000264,000264,000264,000264,000264,000264,000122,000
       Long Term Investments 
218,000
0
259,000
1,880,000
638,000
1,825,000
0
0
0
0001,825,000638,0001,880,000259,0000218,000
       Intangible Assets 
1,320,000
2,056,000
2,206,000
3,523,000
5,673,000
8,039,000
10,427,000
11,736,000
12,887,000
12,887,00011,736,00010,427,0008,039,0005,673,0003,523,0002,206,0002,056,0001,320,000
       Long-term Assets Other 
0
0
0
1,589,000
2,056,000
1,294,000
0
1,756,000
1,631,000
1,631,0001,756,00001,294,0002,056,0001,589,000000
> Total Liabilities 
26,416,000
29,326,000
44,243,000
45,565,000
48,089,000
60,944,000
77,380,000
108,954,000
119,615,000
119,615,000108,954,00077,380,00060,944,00048,089,00045,565,00044,243,00029,326,00026,416,000
   > Total Current Liabilities 
13,796,000
15,547,000
16,657,000
16,783,000
21,413,000
30,385,000
40,080,000
42,101,000
38,280,000
38,280,00042,101,00040,080,00030,385,00021,413,00016,783,00016,657,00015,547,00013,796,000
       Short-term Debt 
8,638,000
866,000
3,949,000
972,000
1,303,000
2,612,000
6,676,000
5,942,000
8,960,000
8,960,0005,942,0006,676,0002,612,0001,303,000972,0003,949,000866,0008,638,000
       Short Long Term Debt 
8,638,000
866,000
104,000
1,943,000
4,735,000
8,814,000
14,032,000
5,942,000
9,055,000
9,055,0005,942,00014,032,0008,814,0004,735,0001,943,000104,000866,0008,638,000
       Accounts payable 
3,472,000
4,293,000
6,098,000
7,397,000
10,053,000
11,983,000
13,251,000
15,139,000
16,085,000
16,085,00015,139,00013,251,00011,983,00010,053,0007,397,0006,098,0004,293,0003,472,000
       Other Current Liabilities 
7,223,000
7,260,000
5,792,000
6,066,000
5,863,000
8,124,000
11,257,000
5,810,000
320,000
320,0005,810,00011,257,0008,124,0005,863,0006,066,0005,792,0007,260,0007,223,000
   > Long-term Liabilities 
0
0
0
25,021,000
21,999,000
24,479,000
30,527,000
58,046,000
70,960,000
70,960,00058,046,00030,527,00024,479,00021,999,00025,021,000000
       Long term Debt Total 
0
0
20,724,000
21,082,000
17,898,000
15,407,000
13,053,000
30,757,000
42,200,000
42,200,00030,757,00013,053,00015,407,00017,898,00021,082,00020,724,00000
       Capital Lease Obligations 
0
0
0
0
7,000
0
899,000
1,225,000
2,426,000
2,426,0001,225,000899,00007,0000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
10,253,000
12,151,000
12,151,00010,253,0000000000
       Deferred Long Term Liability 
472,000
1,370,000
0
0
0
0
0
0
0
00000001,370,000472,000
> Total Stockholder Equity
30,267,000
32,706,000
40,338,000
48,377,000
51,808,000
60,980,000
67,058,000
76,269,000
84,325,000
84,325,00076,269,00067,058,00060,980,00051,808,00048,377,00040,338,00032,706,00030,267,000
   Common Stock
1,000,000
1,000,000
1,000,000
1,000,000
3,000,000
3,000,000
6,000,000
6,000,000
6,003,000
6,003,0006,000,0006,000,0003,000,0003,000,0001,000,0001,000,0001,000,0001,000,000
   Retained Earnings 
24,259,000
27,990,000
35,929,000
42,484,000
45,753,000
55,548,000
60,758,000
67,393,000
73,919,000
73,919,00067,393,00060,758,00055,548,00045,753,00042,484,00035,929,00027,990,00024,259,000
   Capital Surplus 
0
0
2,788,000
2,908,000
1,032,000
1,171,000
238,000
619,000
619,000
619,000619,000238,0001,171,0001,032,0002,908,0002,788,00000
   Treasury Stock0-1,343,000-1,345,000-1,144,000-829,000-727,000-577,00000
   Other Stockholders Equity 
2,220,000
928,000
581,000
2,712,000
2,852,000
2,405,000
1,407,000
2,050,000
2,058,000
2,058,0002,050,0001,407,0002,405,0002,852,0002,712,000581,000928,0002,220,000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue81,840,000
Cost of Revenue-32,055,000
Gross Profit49,785,00049,785,000
 
Operating Income (+$)
Gross Profit49,785,000
Operating Expense-73,147,000
Operating Income11,045,000-23,362,000
 
Operating Expense (+$)
Research Development5,028,000
Selling General Administrative29,209,000
Selling And Marketing Expenses-
Operating Expense73,147,00034,237,000
 
Net Interest Income (+$)
Interest Income1,198,000
Interest Expense-676,000
Net Interest Income445,000522,000
 
Pretax Income (+$)
Operating Income11,045,000
Net Interest Income445,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)9,831,00011,045,000
EBIT - interestExpense = -676,000
6,484,000
7,160,000
Interest Expense676,000
Earnings Before Interest and Taxes (ebit)-10,507,000
Earnings Before Interest and Taxes (ebitda)18,649,000
 
After tax Income (+$)
Income Before Tax9,831,000
Tax Provision-2,115,000
Net Income From Continuing Ops7,716,0007,716,000
Net Income6,484,000
Net Income Applicable To Common Shares6,484,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--445,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CEM.MI
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CEM.MI.

CEM.MI Daily Candlestick Chart
CANCDA.SW
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CANCDA.SW.

CANCDA.SW Daily Candlestick Chart
21W.F
11 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 21W.F.

21W.F Daily Candlestick Chart
CSPX.LSE
30 minutes ago

I found you a Golden Cross on the daily chart of CSPX.LSE.

CSPX.LSE Daily Candlestick Chart
CRL.LSE
31 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRL.LSE.

CRL.LSE Daily Candlestick Chart
CRH.LSE
31 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CRH.LSE.

CRH.LSE Daily Candlestick Chart
ADMIE.AT
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADMIE.AT.

ADMIE.AT Daily Candlestick Chart
DUET.NASDAQ
38 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DUET.NASDAQ.

DUET.NASDAQ Daily Candlestick Chart
POLY.XETRA
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of POLY.XETRA.

POLY.XETRA Daily Candlestick Chart
ENTEL.SN
1 hour ago

I found you a Golden Cross on the daily chart of ENTEL.SN.

ENTEL.SN Daily Candlestick Chart
CENCOSUD.SN
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CENCOSUD.SN.

CENCOSUD.SN Daily Candlestick Chart
ANTARCHILE.SN
1 hour ago

I found you a Death Cross on the daily chart of ANTARCHILE.SN.

ANTARCHILE.SN Daily Candlestick Chart
3BBE.XETRA
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 3BBE.XETRA.

3BBE.XETRA Daily Candlestick Chart
FORUS.SN
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FORUS.SN.

FORUS.SN Daily Candlestick Chart
NGA1L.MI
1 hour ago

I found you a RSI Bullish Reversal Divergence on the daily chart of NGA1L.MI.

NGA1L.MI Daily Candlestick Chart
3CRE.XETRA
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 3CRE.XETRA.

3CRE.XETRA Daily Candlestick Chart
GLGI.OTCQB
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GLGI.OTCQB.

GLGI.OTCQB Daily Candlestick Chart
CCMCUA.SW
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CCMCUA.SW.

CCMCUA.SW Daily Candlestick Chart
AUVI.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AUVI.NASDAQ.

AUVI.NASDAQ Daily Candlestick Chart
AUUD.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AUUD.NASDAQ.

AUUD.NASDAQ Daily Candlestick Chart
AUPH.NASDAQ
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of AUPH.NASDAQ.

AUPH.NASDAQ Daily Candlestick Chart
WIB.STU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WIB.STU.

WIB.STU Daily Candlestick Chart
WFSTF.PINK
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WFSTF.PINK.

WFSTF.PINK Daily Candlestick Chart
WEDXF.PINK
1 hour ago

I found you a Golden Cross on the daily chart of WEDXF.PINK.

WEDXF.PINK Daily Candlestick Chart